可能良性乳腺结节性病变(BI-RADS 3):超声特征与组织学表现的相关性
该回顾性研究以122例超声诊断为BI-RADS 3类的乳腺结节性病变为对象,以细针穿刺细胞学和组织学结果为参考标准,发现7例(5.7%)为恶性,高于文献报告的BI-RADS 3恶性风险低于2%。作者认为囊性病变内细胞成分伴移动性液-液平面、实性病变内小于3 mm无回声成分并非总是良性指征,建议对BI-RADS 3结节的管理不能仅依据分类,还需结合临床和病史资料并采用多学科方法选择需组织学验证的病例。
要点
- BI-RADS 3类结节中恶性占7/122例(5.7%),高于文献报告的低于2%。
- 囊性病变内细胞成分伴移动性液-液平面、实性病变内小于3 mm无回声成分并非总是良性指征。
- 作者认为囊性病变内非均匀回声及伴囊性成分的实性结节(尤其体积大者)应视为可疑。
核心结论
- BI-RADS 3类超声结节中恶性率为7/122例(5.7%),高于文献报告的BI-RADS 3恶性风险低于2%。
- 囊性病变内细胞成分伴移动性液-液平面、实性病变内小于3 mm无回声成分并非总是良性指征。
- 作者认为囊性病变内非均匀回声及伴囊性成分的实性结节性病变(尤其体积大者)应视为可疑。
- 作者认为需进一步研究以建立评估上述病变恶性性质的尺寸标准。
研究设计与样本
- 回顾性研究,纳入122例女性共122个超声结节性病变,均因可能良性病变(BI-RADS 3类)行细针穿刺细胞学和组织学检查。
- 以细胞学和组织学结果为参考标准,评估BI-RADS 3类超声表现的有效性。
关键影像表现/征象
- 囊性病变内可见细胞成分伴移动性液-液平面。
- 实性病变内可见小于3 mm的无回声成分。
- 囊性病变内可见非均匀回声,伴囊性成分的实性结节性病变尤其体积大者。
诊断标准与关键数值
- BI-RADS 3类结节中恶性7/122例(5.7%),高于文献报告的BI-RADS 3恶性风险低于2%。
临床应用与阅片要点
- 作者认为BI-RADS 3类可能良性结节性病变的管理不应仅依据BI-RADS分类,还需结合临床和病史资料,并采用多学科方法选择需要组织学验证而非常规随访的病例。
- 作者认为囊性病变内非均匀回声及伴囊性成分的实性结节性病变(尤其体积大者)应视为可疑。
局限性
- 原文为回顾性研究。
- 原文结论指出需进一步研究以建立评估上述病变恶性性质的尺寸标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The purpose of this retrospective study was to determine the validity of the BI-RADS system in ultrasound findings assigned to BI-RADS 3 category, using cytologic and histologic results as a benchmark. Our study population consisted of 122 ultrasound nodular lesions in 122 women who underwent fine-needle aspiration cytology and biopsy for probably benign lesions (Breast Imaging Reporting and Data System [BI-RADS] category 3). Contrary to what was previously reported in the literature (risk of malignancy of BI-RADS 3 <2%), malignancy was the outcome in seven of 122 cases (5.7%). Our study also found that the presence of a cellular component with a mobile fluid-fluid level in a cystic lesion and small (<3 mm) anechoic components in solid lesions is not always an indication of benignity. Our experience seems to indicate the need to consider the presence of non-homogeneous echoes in the corpuscular cyst and solid nodular lesions with cystic components as suspicious, especially in lesions with large dimensions. Therefore it would be necessary to conduct further studies to establish a dimensional criterion in the assessment of the malignant nature of the mentioned lesions. The management of probably benign nodular lesions should not only be guided by BI-RADS classification; it is also necessary to include clinical and anamnestic data and apply a multidisciplinary approach to select cases that require histologic verification instead of the usual follow-up.
引用
- Pistolese CA, Tosti D, Citraro D, et al. Probably Benign Breast Nodular Lesions (BI-RADS 3): Correlation between Ultrasound Features and Histologic Findings. Ultrasound Med Biol. 2018. PMID: 30340921. doi:10.1016/j.ultrasmedbio.2018.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。